Fundraising Fox

11.2 Capital

San Francisco · Pre-Seed–Series B · 4 people tracked

Fox Verdict
Sign up to see your fit

Investment thesis

Early-stage investor in deep-tech—AI, cybersecurity, quantum, robotics, space tech, synthetic biology—with rare bioengineering focus and technically deep partners who engage with complex product and R&D.

Stage
Pre-Seed–Series B
Check
$500K – $3M
HQ
San Francisco, California, US
Leads rounds
Leads

Team · 4 people

from the firm's website
Shelley Zhuang· Founder and Managing Partnerin𝕏

Former Google computer scientist Shelley Zhuang evaluates AI and security startups with deep search and data-systems expertise, focusing on healthcare/life sciences that prioritize patient care, data quality, privacy and compliance.

David Dorsey· Partnerin𝕏

David Dorsey uses his experience as a former DARPA principal investigator at Lockheed Martin and hands-on expertise in AI/ML, quantum, and RF to help early-stage (~$2M) university spinouts commercialize.

Jacob Smith· Principalin𝕏

Jacob Smith's biochemistry, EMT and MBA background drives a science- and patient-grounded focus on early-stage healthcare, biology and sustainability, shaped by a Midwest-to-San-Francisco career that launched a healthcare fund.

Pramod Gosavi· Principalin𝕏

Pramod Gosavi pairs a 360° operator background—Sun Microsystems engineer, startup product roles, VMware corporate-venture leader (backed JFrog, CloudEndure, VeloCloud)—and seeks founders who build, ship, and commit 10+ years.

Frequently asked questions

What stage does 11.2 Capital invest at?
11.2 Capital invests at the Pre-Seed, Seed, Series A, Series B stages.
What is 11.2 Capital's typical check size?
11.2 Capital typically writes checks of $500K – $3M.
What sectors does 11.2 Capital focus on?
11.2 Capital focuses on AI & Machine Learning, Cybersecurity, Deep Tech, Hardware, Healthtech, Robotics.
Where is 11.2 Capital located?
11.2 Capital is headquartered in San Francisco, US.
Does 11.2 Capital lead rounds?
Yes, 11.2 Capital leads investment rounds.

Similar investors

Featured in lists